全文获取类型
收费全文 | 449篇 |
免费 | 28篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 8篇 |
妇产科学 | 1篇 |
基础医学 | 84篇 |
口腔科学 | 18篇 |
临床医学 | 37篇 |
内科学 | 101篇 |
皮肤病学 | 14篇 |
神经病学 | 37篇 |
特种医学 | 28篇 |
外科学 | 32篇 |
综合类 | 3篇 |
预防医学 | 29篇 |
眼科学 | 3篇 |
药学 | 45篇 |
中国医学 | 1篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 5篇 |
2022年 | 19篇 |
2021年 | 27篇 |
2020年 | 16篇 |
2019年 | 11篇 |
2018年 | 15篇 |
2017年 | 18篇 |
2016年 | 19篇 |
2015年 | 16篇 |
2014年 | 37篇 |
2013年 | 28篇 |
2012年 | 73篇 |
2011年 | 50篇 |
2010年 | 22篇 |
2009年 | 21篇 |
2008年 | 20篇 |
2007年 | 27篇 |
2006年 | 18篇 |
2005年 | 15篇 |
2004年 | 11篇 |
2003年 | 8篇 |
2002年 | 4篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
排序方式: 共有483条查询结果,搜索用时 31 毫秒
61.
Lepage N Chaudhry A Konforte D Shaw J Veljkovic K Dennis A Rashid S Farrell SA 《Clinical biochemistry》2012,45(15):1152-1157
Background/ObjectivesThe Ontario Prenatal Screening Program (OPSP) follows internationally recognized standardized procedures for laboratories and genetics clinics. However, it has been found that some procedures are subject to interpretation, so the current procedures are designed to facilitate a unified approach in the interpretation of literature recommendations. In Ontario, the OPSP offers multiple screening modalities with integrated prenatal screening (including both first and second trimester markers) being the most commonly chosen option. Other screening modalities include first trimester screening, second trimester quad screening, serum integrated screening, and NT-Quad.MethodsThe standardization was based on a literature review and on current practices in Ontario.Results/discussionThe main finding of the review was a paucity of published data relating to the procedures and the decision-making processes involved in prenatal screening. The purpose of this publication is to provide the most up-to-date and pertinent information for clinical laboratory professionals involved with prenatal screening for Down syndrome, trisomy 18 and open neural tube defects. 相似文献
62.
63.
64.
65.
Merani S Petrovic D James I Chopra A Cooper D Freitas E Rauch A di Iulio J John M Lucas M Fitzmaurice K McKiernan S Norris S Kelleher D Klenerman P Gaudieri S 《Hepatology (Baltimore, Md.)》2011,54(2):396-405
The incidence of liver disease progression among subjects with histologically advanced but compensated chronic hepatitis C is incomplete. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial was a randomized study of 3.5 years of maintenance peginterferon treatment on liver disease progression among patients who had not cleared virus on peginterferon and ribavirin therapy. Patients were followed subsequently off therapy. Because maintenance peginterferon treatment did not alter liver disease progression, we analyzed treated and control patients together. Among 1,050 subjects (60% advanced fibrosis, 40% cirrhosis), we determined the rate of progression to cirrhosis over 4 years and of clinical outcomes over 8 years. Among patients with fibrosis, the incidence of cirrhosis was 9.9% per year. Six hundred seventy-nine clinical outcomes occurred among 329 subjects. Initial clinical outcomes occurred more frequently among subjects with cirrhosis (7.5% per year) than subjects with fibrosis (3.3% per year) (P<0.0001). Child-Turcotte-Pugh (CTP) score≥7 was the most common first outcome, followed by hepatocellular carcinoma. Following occurrence of a CTP score≥7, the rate of subsequent events increased to 12.9% per year, including a death rate of 10% per year. Age and sex did not influence outcome rates. Baseline platelet count was a strong predictor of all clinical outcomes. During the 8 years of follow-up, death or liver transplantation occurred among 12.2% of patients with advanced fibrosis and 31.5% of those with cirrhosis. CONCLUSION: Among patients with advanced hepatitis C who failed peginterferon and ribavirin therapy, the rate of liver-related outcomes, including death and liver transplantation, is high, especially once the CTP score reaches at least 7. 相似文献
66.
67.
Danijela Bataveljić Ljiljana Nikolić Milena Milosević Nataša Todorović Pavle R. Andjus 《Glia》2012,60(12):1991-2003
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting upper and lower motor neurons. Dysfunction and death of motor neurons are closely related to the modified astrocytic environment. Astrocytic endfeet, lining the blood–brain barrier (BBB), are enriched in two proteins, aquaporin‐4 (AQP4) and inwardly rectifying potassium channel (Kir) 4.1. Both channels are important for the maintainance of a functional BBB astrocytic lining. In this study, expression levels of AQP4 and Kir4.1 were for the first time examined in the brainstem and cortex, along with the functional properties of Kir channels in cultured cortical astrocytes of the SOD1G93A rat model of ALS. Western blot analysis showed increased expression of AQP4 and decreased expression of Kir4.1 in the brainstem and cortex of the ALS rat. In addition, higher immunoreactivity of AQP4 and reduced immunolabeling of Kir4.1 in facial and trigeminal nuclei as well as in the motor cortex were also observed. Particularly, the observed changes in the expression of both channels were retained in cultured astrocytes. Furthermore, whole‐cell patch‐clamp recordings from cultured ALS cortical astrocytes showed a significantly lower Kir current density. Importantly, the potassium uptake current in ALS astrocytes was significantly reduced at all extracellular potassium concentrations. Consequently, the Kir‐specific Cs+‐ and Ba2+‐sensitive currents were also decreased. The changes in the studied channels, notably at the upper CNS level, could underline the hampered ability of astrocytes to maintain water and potassium homeostasis, thus affecting the BBB, disturbing the neuronal microenvironment, and causing motoneuronal dysfunction and death. © 2012 Wiley Periodicals, Inc. 相似文献
68.
69.
Ivana Raji Dragana Javorac Simona Tatovi Aleksandra Repi Danijela uki-osi Sneana orevi Vera Luki Zorica Bulat 《Arhiv za higijenu rada i toksikologiju》2020,71(1):87
Immunochromatographic strips for urine drug screening tests (UDSTs) are common and very suitable for drug abuse monitoring, but are also highly susceptible to adulterants kept in the household, which can significantly alter test results. The aim of this study was to see how some of these common adulterants affect UDST results in practice and whether they can be detected by sample validity tests with pH and URIT 11G test strips. To this end we added household chemicals (acids, alkalis, oxidizing agents, surfactants, and miscellaneous substances) to urine samples positive for amphetamine, 3,4-methylenedioxymethamphetamine (MDMA), tetrahydrocannabinol, heroin, cocaine, or benzodiazepines (diazepam or alprazolam) and tested them with one-component immunochromatographic UDST strips. The UDST for cocaine resisted adulteration the most, while the cannabis test produced the most false negative results. The most potent adulterant that barely changed the physiological properties of urine specimens and therefore escaped adulteration detection was vinegar. Besides lemon juice, it produced the most false negative test results. In conclusion, some urine adulterants, such as vinegar, could pass urine specimen validity test and remain undetected by laboratory testing. Our findings raise concern about this issue of preventing urine tampering and call for better control at sampling, privacy concerns notwithstanding, and better sample validity tests.Key words: false negative, household chemicals, immunochromatographic assay, lemon juice, URIT 11G, vinegar 相似文献
70.